Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 2020

View Archived Issues

Cross-reactive immunity helps antitumor response

How antidepressants inhibit fibrosis

Interim results from a phase I trial of FixVac RNA vaccine in patients with advanced melanoma

BBT-032 inhibits growth of the SARS-CoV-2 virus in preclinical studies

Expression Therapeutics developing gene therapy candidate for FHL3

TLR adjuvant makes for longer immune responses

Albireo presents new SLC10A2 and/or SLC10A1 inhibitors

DNA polymerase theta inhibitors identified at Ideaya Biosciences

Lilly discovers KCNQ2/3 channel activators

Capulus Therapeutics synthesizes new SREBP inhibitors

New IL-17A/IL-17RA interaction inhibitors patented by DiCE Molecules

Oncology Venture to advance stenoparib into clinical trials for COVID-19

MK-4710: a new potent, selective, brain-penetrant M4R PAM suitable for clinical development

Debiopharm begins phase I study of Debio-1124 for small cell carcinoma

Novartis details development of best-in-class LTA4 hydrolase inhibitor LYS-006

Conditional E.U. approval for Idefirix for highly sensitized kidney transplant patients

FDA approves Winlevi for acne

New phase II study investigates pelareorep with retifanlimab for triple-negative breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...